Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer

• Asıl Yazarlar: Maojin You (Yazar), Ruijia Chen (Yazar), Qingfeng Wu (Yazar), Wei Zhu (Yazar), Ying He (Yazar), Yufan Huang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: The findings of the CAPSTONE-1 trial showed that adebrelimab in combination with chemotherapy (etoposide-carboplatin) (ADCHM) is clinically beneficial as a first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC), compared with placebo plus chemotherapy (PL...